NCT05313893View on ClinicalTrials.gov

A Clinical Trial of an Inactivated Quadrivalent Influenza Vaccine in Chinese Children Aged 3 to 8 Years

PHASE4CompletedINTERVENTIONAL
Enrollment

252

Participants

Timeline

Start Date

September 11, 2021

Primary Completion Date

December 25, 2021

Study Completion Date

May 30, 2022

Conditions
Influenza
Interventions
BIOLOGICAL

Quadrivalent influenza vaccine

Subjects receive two doses of quadrivalent influenzavaccine administered 4 weeks apart by intramuscularinjection. Each 0.5-ml dosecontained 15 μg of hemagglutinin per strain.

Trial Locations (1)

222300

Donghai County Center for Disease Control and Prevention, Lianyungang

All Listed Sponsors
lead

Jiangsu Province Centers for Disease Control and Prevention

NETWORK

NCT05313893 - A Clinical Trial of an Inactivated Quadrivalent Influenza Vaccine in Chinese Children Aged 3 to 8 Years | Biotech Hunter | Biotech Hunter